Genentech

OCREVUS

  1. Home
  2.  / 
  3. J Code
  4.  / OCREVUS – J2350

Manufacturer:

Genentech

Name:

OCREVUS

HCPCS Code Descriptor:

Injection, ocrelizumab, 1 mg

Category:

J Code

HCPCS:

J2350

NDC(s):

50242-0150-01

Primary Type:

Neurology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

OCREVUS is a Neurology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J2350 is aligned to the drug OCREVUS.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/18

HCPCS Effective Date:

1/1/18

HCPCS Short Description:

Injection, ocrelizumab, 1 mg

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/OCREVUS-Billing-Coding-for-MS.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation